PCR screening of miRNA in AIONFH cases and health control

Published: 15 Mar 2019 | Version 1 | DOI: 10.17632/sd88yf37r2.1
Contributor(s):

Description of this data

MiRCURY LNATM Universal RT microRNA PCR Panels is utlized to analyze the spectra of miRNAs in serum samples from AIONFH patients and applied the random variance model (RVM) t-test to filter the differentially expressed miRNAs. The distinguishable miRNA expression profiles among AIONFH patients and healthy controls were demonstrated by the results of hierarchical clustering. Initial analysis revealed 10 miRNAs that were differentially expressed. Seven miRNAs (miR-127-3p, miR-1, miR-654-3p, miR-628-3p, miR-432-5p, miR-582-3p, and miR-323a-3p) were found to be significantly downregulated (P<0.01), while three miRNAs (miR-483-5p, miR-483-3p, and miR-885-5p) were markedly upregulated (P<0.01)

Experiment data files

Steps to reproduce

Total miRNAs were measured from two pooled serum groups each consisting of a pool of 5 AIONFH serum samples and a pool of 5 healthy serum samples to identify differentially expressed miRNAs. miRNAs were isolated and extracted from serum in a standard method according to the manufacturers’ recommendations (Invitrogen, Carlsbad, CA, USA). Briefly, the serum samples from both groups were centrifuged at 13000×g for 5 min at 4°C to eliminate pellet and cell debris. The supernatant serum was collected and added to TRIzol-LS (Invitrogen, Carlsbad, CA, USA), and then high-speed centrifugation was performed to obtain the aqueous phase. To precipitate the total RNA, serum was mixed with isopropyl alcohol and subjected to one further high-speed centrifugation at 10000×g for 5 min at 4°C. The total RNA was eluted in RNase-free water and stored at -80°C until analysis. The amount and purity of RNA was estimated by ultraviolet spectrophotometer.

MiRNAs were profiled with miRCURY LNATM Universal RT microRNA PCR Panels (Exiqon, Vedbaek, Denmark). RNA samples were diluted to 1.5-1.8 ng/μl using nuclease-free water. The specific miRNA primers for reverse transcription (RT) were used to amplify miRNAs in an RT reaction mix (Exiqon, Denmark) and subjected to amplification using SYBR™ Green Master Mix (Exiqon, Denmark) with an ABI PRISM 7900 Real-time PCR System (Applied Biosystems, USA). Quantitative miRNA expression levels were analyzed by 2^-ΔCt/ΔCt calculation with GenEx qPCR analysis software (Exiqon, Vedbaek, Denmark). Fold changes>2-fold or P<0.05 were used to identify miRNAs that had significantly altered expression between the patient group and the healthy control group.

Latest version

  • Version 1

    2019-03-15

    Published: 2019-03-15

    DOI: 10.17632/sd88yf37r2.1

    Cite this dataset

    Hong, Guoju (2019), “PCR screening of miRNA in AIONFH cases and health control”, Mendeley Data, v1 http://dx.doi.org/10.17632/sd88yf37r2.1

Statistics

Views: 64
Downloads: 4

Institutions

Guangzhou University of Chinese Medicine, University of Western Australia, University of Alberta Department of Surgery

Categories

MicroRNA, Microarray, Real-Time Polymerase Chain Reaction

Licence

CC BY 4.0 Learn more

The files associated with this dataset are licensed under a Creative Commons Attribution 4.0 International licence.

What does this mean?
You can share, copy and modify this dataset so long as you give appropriate credit, provide a link to the CC BY license, and indicate if changes were made, but you may not do so in a way that suggests the rights holder has endorsed you or your use of the dataset. Note that further permission may be required for any content within the dataset that is identified as belonging to a third party.

Report